Sheridan Capital Partners completed the acquisition of a minority stake in RS&A.

Sheridan Capital Partners, a healthcare private equity firm, completed the acquisition of a minority stake in RS&A, a medical device independent service provider. Financial terms were not disclosed. “The entire RSA leadership team and I are excited for the next chapter of growth in partnership with Sheridan. Sheridan’s investment and healthcare expertise will amplify our ability to deliver responsive, professional, and high-quality services to our valued clients and help improve patient care," DJ Conrad, RSA CEO.